Cargando…

Effect of a Fibroin Enzymatic Hydrolysate on Memory Improvement: A Placebo-Controlled, Double-Blind Study

The consumption of a specifically prepared silk fibroin protein enzymatic hydrolysate (FPEH) has been reported to improve cognitive function in healthy humans. The objective of the current study is to evaluate the dose-dependent effects of the FPEH on memory. Healthy adults with an average age of ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Yong Koo, Lee, Boo Yong, Bucci, Luke R., Stohs, Sidney J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852809/
https://www.ncbi.nlm.nih.gov/pubmed/29462997
http://dx.doi.org/10.3390/nu10020233
_version_ 1783306639869214720
author Kang, Yong Koo
Lee, Boo Yong
Bucci, Luke R.
Stohs, Sidney J.
author_facet Kang, Yong Koo
Lee, Boo Yong
Bucci, Luke R.
Stohs, Sidney J.
author_sort Kang, Yong Koo
collection PubMed
description The consumption of a specifically prepared silk fibroin protein enzymatic hydrolysate (FPEH) has been reported to improve cognitive function in healthy humans. The objective of the current study is to evaluate the dose-dependent effects of the FPEH on memory. Healthy adults with an average age of approximately 55 years were administered doses of 0, 280, 400 and 600 mg of FPEH per day in two divided doses for 3 weeks. The Rey–Kim Auditory Verbal Learning Test and the Rey–Kim Complex Figure Test of the Rey–Kim Memory Test were used to evaluate memory at baseline and after 3 weeks. The scores for each test were combined into the memory quotient score (MQ). Learning gradient, memory maintenance, retrieval efficacy, and drawing/recall scores were also compared. After 3 weeks of FPEH, dose-dependent increases were observed for the MQ, the learning gradient, the numbers of words remembered, the retrieval efficiency, and drawing/recall. The optimal dose for FPEH was 400 or 600 mg, depending on the end point measured. No adverse effects were reported. FPEH significantly improved measurements of memory in healthy adults by 3 weeks at doses over 280 mg daily, with an apparent plateau effect at 400–600 mg daily.
format Online
Article
Text
id pubmed-5852809
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-58528092018-03-19 Effect of a Fibroin Enzymatic Hydrolysate on Memory Improvement: A Placebo-Controlled, Double-Blind Study Kang, Yong Koo Lee, Boo Yong Bucci, Luke R. Stohs, Sidney J. Nutrients Article The consumption of a specifically prepared silk fibroin protein enzymatic hydrolysate (FPEH) has been reported to improve cognitive function in healthy humans. The objective of the current study is to evaluate the dose-dependent effects of the FPEH on memory. Healthy adults with an average age of approximately 55 years were administered doses of 0, 280, 400 and 600 mg of FPEH per day in two divided doses for 3 weeks. The Rey–Kim Auditory Verbal Learning Test and the Rey–Kim Complex Figure Test of the Rey–Kim Memory Test were used to evaluate memory at baseline and after 3 weeks. The scores for each test were combined into the memory quotient score (MQ). Learning gradient, memory maintenance, retrieval efficacy, and drawing/recall scores were also compared. After 3 weeks of FPEH, dose-dependent increases were observed for the MQ, the learning gradient, the numbers of words remembered, the retrieval efficiency, and drawing/recall. The optimal dose for FPEH was 400 or 600 mg, depending on the end point measured. No adverse effects were reported. FPEH significantly improved measurements of memory in healthy adults by 3 weeks at doses over 280 mg daily, with an apparent plateau effect at 400–600 mg daily. MDPI 2018-02-17 /pmc/articles/PMC5852809/ /pubmed/29462997 http://dx.doi.org/10.3390/nu10020233 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kang, Yong Koo
Lee, Boo Yong
Bucci, Luke R.
Stohs, Sidney J.
Effect of a Fibroin Enzymatic Hydrolysate on Memory Improvement: A Placebo-Controlled, Double-Blind Study
title Effect of a Fibroin Enzymatic Hydrolysate on Memory Improvement: A Placebo-Controlled, Double-Blind Study
title_full Effect of a Fibroin Enzymatic Hydrolysate on Memory Improvement: A Placebo-Controlled, Double-Blind Study
title_fullStr Effect of a Fibroin Enzymatic Hydrolysate on Memory Improvement: A Placebo-Controlled, Double-Blind Study
title_full_unstemmed Effect of a Fibroin Enzymatic Hydrolysate on Memory Improvement: A Placebo-Controlled, Double-Blind Study
title_short Effect of a Fibroin Enzymatic Hydrolysate on Memory Improvement: A Placebo-Controlled, Double-Blind Study
title_sort effect of a fibroin enzymatic hydrolysate on memory improvement: a placebo-controlled, double-blind study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852809/
https://www.ncbi.nlm.nih.gov/pubmed/29462997
http://dx.doi.org/10.3390/nu10020233
work_keys_str_mv AT kangyongkoo effectofafibroinenzymatichydrolysateonmemoryimprovementaplacebocontrolleddoubleblindstudy
AT leebooyong effectofafibroinenzymatichydrolysateonmemoryimprovementaplacebocontrolleddoubleblindstudy
AT bucciluker effectofafibroinenzymatichydrolysateonmemoryimprovementaplacebocontrolleddoubleblindstudy
AT stohssidneyj effectofafibroinenzymatichydrolysateonmemoryimprovementaplacebocontrolleddoubleblindstudy